Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolfgang Hackl

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Radiation Oncology (London, England)|March 29, 2012
NVP-BEZ235 and NVP-BGT226, dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitors, enhance tumor and endothelial cell radiosensitivityEmmanouil Fokas, Michio Yoshimura, Remko Prevo, et al.
Molecular Cancer Research : MCR|October 20, 2011
Inhibition of DNA-dependent protein kinase induces accelerated senescence in irradiated human cancer cellsArun Azad, Susan Jackson, Carleen Cullinane, et al.
Cancer|October 19, 2006
Serum epidermal growth factor receptor/HER-2 predicts poor survival in patients with metastatic breast cancerChristopher Souder, Kim Leitzel, Suhail M Ali, et al.
Plos One|February 23, 2012
Multi-level targeting of the phosphatidylinositol-3-kinase pathway in non-small cell lung cancer cellsChristopher R Zito, Lucia B Jilaveanu, Valsamo Anagnostou, et al.
Cancer|June 14, 2005
Serum HER-2/neu conversion to positive at the time of disease progression in patients with breast carcinoma on hormone therapyAllan Lipton, Kim Leitzel, Suhail M Ali, et al.
Cancer Research|November 24, 2011
Dual inhibition of the PI3K/mTOR pathway increases tumor radiosensitivity by normalizing tumor vasculatureEmmanouil Fokas, Jae Hong Im, Sally Hill, et al.
Nanotechnology|August 7, 2012
Nano- and microstructuring of graphene using UV-NILIris Bergmair, Wolfgang Hackl, Maria Losurdo, et al.
JAMA Oncology|June 15, 2018
Association of Somatic Driver Alterations With Prognosis in Postmenopausal, Hormone Receptor-Positive, HER2-Negative Early Breast Cancer: A Secondary Analysis of the BIG 1-98 Randomized Clinical TrialStephen J Luen, Rebecca Asher, Chee Khoon Lee, et al.
Cancer Chemotherapy and Pharmacology|June 9, 2018
Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancerJordi Rodon, Alejandro Pérez-Fidalgo, Ian E Krop, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Radiation Oncology (London, England)|March 29, 2012
NVP-BEZ235 and NVP-BGT226, dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitors, enhance tumor and endothelial cell radiosensitivityEmmanouil Fokas, Michio Yoshimura, Remko Prevo, et al.
Molecular Cancer Research : MCR|October 20, 2011
Inhibition of DNA-dependent protein kinase induces accelerated senescence in irradiated human cancer cellsArun Azad, Susan Jackson, Carleen Cullinane, et al.
Cancer|October 19, 2006
Serum epidermal growth factor receptor/HER-2 predicts poor survival in patients with metastatic breast cancerChristopher Souder, Kim Leitzel, Suhail M Ali, et al.
Plos One|February 23, 2012
Multi-level targeting of the phosphatidylinositol-3-kinase pathway in non-small cell lung cancer cellsChristopher R Zito, Lucia B Jilaveanu, Valsamo Anagnostou, et al.
Cancer|June 14, 2005
Serum HER-2/neu conversion to positive at the time of disease progression in patients with breast carcinoma on hormone therapyAllan Lipton, Kim Leitzel, Suhail M Ali, et al.
Cancer Research|November 24, 2011
Dual inhibition of the PI3K/mTOR pathway increases tumor radiosensitivity by normalizing tumor vasculatureEmmanouil Fokas, Jae Hong Im, Sally Hill, et al.
Nanotechnology|August 7, 2012
Nano- and microstructuring of graphene using UV-NILIris Bergmair, Wolfgang Hackl, Maria Losurdo, et al.
JAMA Oncology|June 15, 2018
Association of Somatic Driver Alterations With Prognosis in Postmenopausal, Hormone Receptor-Positive, HER2-Negative Early Breast Cancer: A Secondary Analysis of the BIG 1-98 Randomized Clinical TrialStephen J Luen, Rebecca Asher, Chee Khoon Lee, et al.
Cancer Chemotherapy and Pharmacology|June 9, 2018
Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancerJordi Rodon, Alejandro Pérez-Fidalgo, Ian E Krop, et al.
Pageof 2